APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Second-Generation Antipsychotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Second-Generation Antipsychotics Market Analysis and Forecast 2026-2032

Report ID 174034400223 December 2025204 pages

Choose your research edition.

Industry ResearchSecond-Generation Antipsychotics Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Second-Generation Antipsychotics Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Second-Generation Antipsychotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Second-Generation Antipsychotics Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Second-Generation Antipsychotics Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Second-Generation Antipsychotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Second-Generation Antipsychotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Second-Generation Antipsychotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Second-Generation Antipsychotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Second-Generation Antipsychotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Second-Generation Antipsychotics include Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical Group, CSPC Pharmaceutical Group, Qilu Pharmaceutical, Novartis, Merck, Luye Pharma Group, Roche and Livzon Pharmaceutical Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Second-Generation Antipsychotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Second-Generation Antipsychotics, also provides the sales of main regions and countries. Of the upcoming market potential for Second-Generation Antipsychotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Second-Generation Antipsychotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Second-Generation Antipsychotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Second-Generation Antipsychotics sales, projected growth trends, production technology, application and end-user industry.

Second-Generation Antipsychotics Segment by Company

Chia Tai Tianqing Pharmaceutical

Yangtze River Pharmaceutical Group

CSPC Pharmaceutical Group

Qilu Pharmaceutical

Novartis

Merck

Luye Pharma Group

Roche

Livzon Pharmaceutical Group

Eli Lilly

Chengdu Kanghong Pharmaceutical

Pfizer

Hansoh Pharma

Hisun Pharmaceutical

Nhwa Pharmaceutical

AbbVie

Sumitomo Dainippon Pharma

Otsuka Pharmaceutical

Johnson And Johnson

Ipsen

Second-Generation Antipsychotics Segment by Type

Selective Dopamine Receptor Antagonists

Multi Receptor Acting Drugs

Dopamine Receptor Partial Agonists

5-Hydroxytryptamine And Dopamine Receptor Antagonists

Second-Generation Antipsychotics Segment by Application

Adjuvant Treatment For Depression

Bipolar Disorder

Schizophrenia

Other Mental Illnesses

Second-Generation Antipsychotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Second-Generation Antipsychotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Second-Generation Antipsychotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Second-Generation Antipsychotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Second-Generation Antipsychotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Second-Generation Antipsychotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Second-Generation Antipsychotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Second-Generation Antipsychotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Selective Dopamine Receptor Antagonists Major Manufacturers Table 3. Multi Receptor Acting Drugs Major Manufacturers Table 4. Dopamine Receptor Partial Agonists Major Manufacturers Table 5. 5-Hydroxytryptamine And Dopamine Receptor Antagonists Major Manufacturers Table 6. Global Second-Generation Antipsychotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adjuvant Treatment For Depression Major Manufacturers Table 8. Bipolar Disorder Major Manufacturers Table 9. Schizophrenia Major Manufacturers Table 10. Other Mental Illnesses Major Manufacturers Table 11. Second-Generation Antipsychotics Industry Trends Table 12. Second-Generation Antipsychotics Industry Drivers Table 13. Second-Generation Antipsychotics Industry Opportunities and Challenges Table 14. Second-Generation Antipsychotics Industry Restraints Table 15. Global Second-Generation Antipsychotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Second-Generation Antipsychotics Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Second-Generation Antipsychotics Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Second-Generation Antipsychotics Revenue Market Share by Region (2021-2026) Table 19. Global Second-Generation Antipsychotics Revenue Market Share by Region (2027-2032) Table 20. Global Second-Generation Antipsychotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 21. Global Second-Generation Antipsychotics Sales by Region (2021-2026) & (units) Table 22. Global Second-Generation Antipsychotics Sales by Region (2027-2032) & (units) Table 23. Global Second-Generation Antipsychotics Sales Market Share by Region (2021-2026) Table 24. Global Second-Generation Antipsychotics Sales Market Share by Region (2027-2032) Table 25. Global Second-Generation Antipsychotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Second-Generation Antipsychotics Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Second-Generation Antipsychotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Second-Generation Antipsychotics Sales Market Share by Manufacturers (2021-2026) Table 29. Global Second-Generation Antipsychotics Sales Price (USD/unit) of Manufacturers (2021-2026) Table 30. Global Second-Generation Antipsychotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Second-Generation Antipsychotics Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Second-Generation Antipsychotics Manufacturers, Product Type & Application Table 33. Global Second-Generation Antipsychotics Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Second-Generation Antipsychotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Second-Generation Antipsychotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Second-Generation Antipsychotics Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Second-Generation Antipsychotics Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Second-Generation Antipsychotics Revenue Market Share by Type (2021-2026) Table 40. Global Second-Generation Antipsychotics Revenue Market Share by Type (2027-2032) Table 41. Global Second-Generation Antipsychotics Sales by Type 2021 VS 2025 VS 2032 (units) Table 42. Global Second-Generation Antipsychotics Sales by Type (2021-2026) & (units) Table 43. Global Second-Generation Antipsychotics Sales by Type (2027-2032) & (units) Table 44. Global Second-Generation Antipsychotics Sales Market Share by Type (2021-2026) Table 45. Global Second-Generation Antipsychotics Sales Market Share by Type (2027-2032) Table 46. Global Second-Generation Antipsychotics Price by Type (2021-2026) & (USD/unit) Table 47. Global Second-Generation Antipsychotics Price by Type (2027-2032) & (USD/unit) Table 48. Global Second-Generation Antipsychotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Second-Generation Antipsychotics Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Second-Generation Antipsychotics Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Second-Generation Antipsychotics Revenue Market Share by Application (2021-2026) Table 52. Global Second-Generation Antipsychotics Revenue Market Share by Application (2027-2032) Table 53. Global Second-Generation Antipsychotics Sales by Application 2021 VS 2025 VS 2032 (units) Table 54. Global Second-Generation Antipsychotics Sales by Application (2021-2026) & (units) Table 55. Global Second-Generation Antipsychotics Sales by Application (2027-2032) & (units) Table 56. Global Second-Generation Antipsychotics Sales Market Share by Application (2021-2026) Table 57. Global Second-Generation Antipsychotics Sales Market Share by Application (2027-2032) Table 58. Global Second-Generation Antipsychotics Price by Application (2021-2026) & (USD/unit) Table 59. Global Second-Generation Antipsychotics Price by Application (2027-2032) & (USD/unit) Table 60. Chia Tai Tianqing Pharmaceutical Company Information Table 61. Chia Tai Tianqing Pharmaceutical Business Overview Table 62. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 63. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Portfolio Table 64. Chia Tai Tianqing Pharmaceutical Recent Development Table 65. Yangtze River Pharmaceutical Group Company Information Table 66. Yangtze River Pharmaceutical Group Business Overview Table 67. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio Table 69. Yangtze River Pharmaceutical Group Recent Development Table 70. CSPC Pharmaceutical Group Company Information Table 71. CSPC Pharmaceutical Group Business Overview Table 72. CSPC Pharmaceutical Group Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio Table 74. CSPC Pharmaceutical Group Recent Development Table 75. Qilu Pharmaceutical Company Information Table 76. Qilu Pharmaceutical Business Overview Table 77. Qilu Pharmaceutical Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Qilu Pharmaceutical Second-Generation Antipsychotics Product Portfolio Table 79. Qilu Pharmaceutical Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Novartis Second-Generation Antipsychotics Product Portfolio Table 84. Novartis Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Merck Second-Generation Antipsychotics Product Portfolio Table 89. Merck Recent Development Table 90. Luye Pharma Group Company Information Table 91. Luye Pharma Group Business Overview Table 92. Luye Pharma Group Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Luye Pharma Group Second-Generation Antipsychotics Product Portfolio Table 94. Luye Pharma Group Recent Development Table 95. Roche Company Information Table 96. Roche Business Overview Table 97. Roche Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Roche Second-Generation Antipsychotics Product Portfolio Table 99. Roche Recent Development Table 100. Livzon Pharmaceutical Group Company Information Table 101. Livzon Pharmaceutical Group Business Overview Table 102. Livzon Pharmaceutical Group Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio Table 104. Livzon Pharmaceutical Group Recent Development Table 105. Eli Lilly Company Information Table 106. Eli Lilly Business Overview Table 107. Eli Lilly Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Eli Lilly Second-Generation Antipsychotics Product Portfolio Table 109. Eli Lilly Recent Development Table 110. Chengdu Kanghong Pharmaceutical Company Information Table 111. Chengdu Kanghong Pharmaceutical Business Overview Table 112. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Portfolio Table 114. Chengdu Kanghong Pharmaceutical Recent Development Table 115. Pfizer Company Information Table 116. Pfizer Business Overview Table 117. Pfizer Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Pfizer Second-Generation Antipsychotics Product Portfolio Table 119. Pfizer Recent Development Table 120. Hansoh Pharma Company Information Table 121. Hansoh Pharma Business Overview Table 122. Hansoh Pharma Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Hansoh Pharma Second-Generation Antipsychotics Product Portfolio Table 124. Hansoh Pharma Recent Development Table 125. Hisun Pharmaceutical Company Information Table 126. Hisun Pharmaceutical Business Overview Table 127. Hisun Pharmaceutical Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Hisun Pharmaceutical Second-Generation Antipsychotics Product Portfolio Table 129. Hisun Pharmaceutical Recent Development Table 130. Nhwa Pharmaceutical Company Information Table 131. Nhwa Pharmaceutical Business Overview Table 132. Nhwa Pharmaceutical Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Nhwa Pharmaceutical Second-Generation Antipsychotics Product Portfolio Table 134. Nhwa Pharmaceutical Recent Development Table 135. AbbVie Company Information Table 136. AbbVie Business Overview Table 137. AbbVie Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. AbbVie Second-Generation Antipsychotics Product Portfolio Table 139. AbbVie Recent Development Table 140. Sumitomo Dainippon Pharma Company Information Table 141. Sumitomo Dainippon Pharma Business Overview Table 142. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Portfolio Table 144. Sumitomo Dainippon Pharma Recent Development Table 145. Otsuka Pharmaceutical Company Information Table 146. Otsuka Pharmaceutical Business Overview Table 147. Otsuka Pharmaceutical Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Otsuka Pharmaceutical Second-Generation Antipsychotics Product Portfolio Table 149. Otsuka Pharmaceutical Recent Development Table 150. Johnson And Johnson Company Information Table 151. Johnson And Johnson Business Overview Table 152. Johnson And Johnson Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Johnson And Johnson Second-Generation Antipsychotics Product Portfolio Table 154. Johnson And Johnson Recent Development Table 155. Ipsen Company Information Table 156. Ipsen Business Overview Table 157. Ipsen Second-Generation Antipsychotics Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Ipsen Second-Generation Antipsychotics Product Portfolio Table 159. Ipsen Recent Development Table 160. North America Second-Generation Antipsychotics Revenue by Type (2021-2026) & (US$ Million) Table 161. North America Second-Generation Antipsychotics Revenue by Type (2027-2032) & (US$ Million) Table 162. North America Second-Generation Antipsychotics Sales by Type (2021-2026) & (units) Table 163. North America Second-Generation Antipsychotics Sales by Type (2027-2032) & (units) Table 164. North America Second-Generation Antipsychotics Sales Price by Type (2021-2026) & (USD/unit) Table 165. North America Second-Generation Antipsychotics Sales Price by Type (2027-2032) & (USD/unit) Table 166. North America Second-Generation Antipsychotics Revenue by Application (2021-2026) & (US$ Million) Table 167. North America Second-Generation Antipsychotics Revenue by Application (2027-2032) & (US$ Million) Table 168. North America Second-Generation Antipsychotics Sales by Application (2021-2026) & (units) Table 169. North America Second-Generation Antipsychotics Sales by Application (2027-2032) & (units) Table 170. North America Second-Generation Antipsychotics Sales Price by Application (2021-2026) & (USD/unit) Table 171. North America Second-Generation Antipsychotics Sales Price by Application (2027-2032) & (USD/unit) Table 172. North America Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. North America Second-Generation Antipsychotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. North America Second-Generation Antipsychotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. North America Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032) & (units) Table 176. North America Second-Generation Antipsychotics Sales by Country (2021-2026) & (units) Table 177. North America Second-Generation Antipsychotics Sales by Country (2027-2032) & (units) Table 178. North America Second-Generation Antipsychotics Sales Price by Country (2021-2026) & (USD/unit) Table 179. North America Second-Generation Antipsychotics Sales Price by Country (2027-2032) & (USD/unit) Table 180. United States Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 181. Canada Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 182. Mexico Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 183. Europe Second-Generation Antipsychotics Revenue by Type (2021-2026) & (US$ Million) Table 184. Europe Second-Generation Antipsychotics Revenue by Type (2027-2032) & (US$ Million) Table 185. Europe Second-Generation Antipsychotics Sales by Type (2021-2026) & (units) Table 186. Europe Second-Generation Antipsychotics Sales by Type (2027-2032) & (units) Table 187. Europe Second-Generation Antipsychotics Sales Price by Type (2021-2026) & (USD/unit) Table 188. Europe Second-Generation Antipsychotics Sales Price by Type (2027-2032) & (USD/unit) Table 189. Europe Second-Generation Antipsychotics Revenue by Application (2021-2026) & (US$ Million) Table 190. Europe Second-Generation Antipsychotics Revenue by Application (2027-2032) & (US$ Million) Table 191. Europe Second-Generation Antipsychotics Sales by Application (2021-2026) & (units) Table 192. Europe Second-Generation Antipsychotics Sales by Application (2027-2032) & (units) Table 193. Europe Second-Generation Antipsychotics Sales Price by Application (2021-2026) & (USD/unit) Table 194. Europe Second-Generation Antipsychotics Sales Price by Application (2027-2032) & (USD/unit) Table 195. Europe Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Europe Second-Generation Antipsychotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Europe Second-Generation Antipsychotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Europe Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032) & (units) Table 199. Europe Second-Generation Antipsychotics Sales by Country (2021-2026) & (units) Table 200. Europe Second-Generation Antipsychotics Sales by Country (2027-2032) & (units) Table 201. Europe Second-Generation Antipsychotics Sales Price by Country (2021-2026) & (USD/unit) Table 202. Europe Second-Generation Antipsychotics Sales Price by Country (2027-2032) & (USD/unit) Table 203. Germany Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 204. France Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 205. U.K. Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 206. Italy Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 207. Russia Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 208. Spain Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 209. Netherlands Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 210. Switzerland Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 211. Sweden Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 212. Poland Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 213. China Second-Generation Antipsychotics Revenue by Type (2021-2026) & (US$ Million) Table 214. China Second-Generation Antipsychotics Revenue by Type (2027-2032) & (US$ Million) Table 215. China Second-Generation Antipsychotics Sales by Type (2021-2026) & (units) Table 216. China Second-Generation Antipsychotics Sales by Type (2027-2032) & (units) Table 217. China Second-Generation Antipsychotics Sales Price by Type (2021-2026) & (USD/unit) Table 218. China Second-Generation Antipsychotics Sales Price by Type (2027-2032) & (USD/unit) Table 219. China Second-Generation Antipsychotics Revenue by Application (2021-2026) & (US$ Million) Table 220. China Second-Generation Antipsychotics Revenue by Application (2027-2032) & (US$ Million) Table 221. China Second-Generation Antipsychotics Sales by Application (2021-2026) & (units) Table 222. China Second-Generation Antipsychotics Sales by Application (2027-2032) & (units) Table 223. China Second-Generation Antipsychotics Sales Price by Application (2021-2026) & (USD/unit) Table 224. China Second-Generation Antipsychotics Sales Price by Application (2027-2032) & (USD/unit) Table 225. Asia Second-Generation Antipsychotics Revenue by Type (2021-2026) & (US$ Million) Table 226. Asia Second-Generation Antipsychotics Revenue by Type (2027-2032) & (US$ Million) Table 227. Asia Second-Generation Antipsychotics Sales by Type (2021-2026) & (units) Table 228. Asia Second-Generation Antipsychotics Sales by Type (2027-2032) & (units) Table 229. Asia Second-Generation Antipsychotics Sales Price by Type (2021-2026) & (USD/unit) Table 230. Asia Second-Generation Antipsychotics Sales Price by Type (2027-2032) & (USD/unit) Table 231. Asia Second-Generation Antipsychotics Revenue by Application (2021-2026) & (US$ Million) Table 232. Asia Second-Generation Antipsychotics Revenue by Application (2027-2032) & (US$ Million) Table 233. Asia Second-Generation Antipsychotics Sales by Application (2021-2026) & (units) Table 234. Asia Second-Generation Antipsychotics Sales by Application (2027-2032) & (units) Table 235. Asia Second-Generation Antipsychotics Sales Price by Application (2021-2026) & (USD/unit) Table 236. Asia Second-Generation Antipsychotics Sales Price by Application (2027-2032) & (USD/unit) Table 237. Asia Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 238. Asia Second-Generation Antipsychotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 239. Asia Second-Generation Antipsychotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 240. Asia Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032) & (units) Table 241. Asia Second-Generation Antipsychotics Sales by Country (2021-2026) & (units) Table 242. Asia Second-Generation Antipsychotics Sales by Country (2027-2032) & (units) Table 243. Asia Second-Generation Antipsychotics Sales Price by Country (2021-2026) & (USD/unit) Table 244. Asia Second-Generation Antipsychotics Sales Price by Country (2027-2032) & (USD/unit) Table 245. Japan Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 246. South Korea Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 247. India Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 248. Australia Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 249. Taiwan Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 250. Southeast Asia Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 251. SAMEA Second-Generation Antipsychotics Revenue by Type (2021-2026) & (US$ Million) Table 252. SAMEA Second-Generation Antipsychotics Revenue by Type (2027-2032) & (US$ Million) Table 253. SAMEA Second-Generation Antipsychotics Sales by Type (2021-2026) & (units) Table 254. SAMEA Second-Generation Antipsychotics Sales by Type (2027-2032) & (units) Table 255. SAMEA Second-Generation Antipsychotics Sales Price by Type (2021-2026) & (USD/unit) Table 256. SAMEA Second-Generation Antipsychotics Sales Price by Type (2027-2032) & (USD/unit) Table 257. SAMEA Second-Generation Antipsychotics Revenue by Application (2021-2026) & (US$ Million) Table 258. SAMEA Second-Generation Antipsychotics Revenue by Application (2027-2032) & (US$ Million) Table 259. SAMEA Second-Generation Antipsychotics Sales by Application (2021-2026) & (units) Table 260. SAMEA Second-Generation Antipsychotics Sales by Application (2027-2032) & (units) Table 261. SAMEA Second-Generation Antipsychotics Sales Price by Application (2021-2026) & (USD/unit) Table 262. SAMEA Second-Generation Antipsychotics Sales Price by Application (2027-2032) & (USD/unit) Table 263. SAMEA Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 264. SAMEA Second-Generation Antipsychotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 265. SAMEA Second-Generation Antipsychotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 266. SAMEA Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032) & (units) Table 267. SAMEA Second-Generation Antipsychotics Sales by Country (2021-2026) & (units) Table 268. SAMEA Second-Generation Antipsychotics Sales by Country (2027-2032) & (units) Table 269. SAMEA Second-Generation Antipsychotics Sales Price by Country (2021-2026) & (USD/unit) Table 270. SAMEA Second-Generation Antipsychotics Sales Price by Country (2027-2032) & (USD/unit) Table 271. Brazil Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 272. Argentina Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 273. Chile Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 274. Colombia Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 275. Peru Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 276. Saudi Arabia Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 277. Israel Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 278. UAE Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 279. Turkey Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 280. Iran Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 281. Egypt Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Table 282. Key Raw Materials Table 283. Raw Materials Key Suppliers Table 284. Second-Generation Antipsychotics Distributors List Table 285. Second-Generation Antipsychotics Customers List Table 286. Research Programs/Design for This Report Table 287. Authors List of This Report Table 288. Secondary Sources Table 289. Primary Sources List of Figures Figure 1. Second-Generation Antipsychotics Image Figure 2. Global Second-Generation Antipsychotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Second-Generation Antipsychotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Selective Dopamine Receptor Antagonists Image Figure 5. Multi Receptor Acting Drugs Image Figure 6. Dopamine Receptor Partial Agonists Image Figure 7. 5-Hydroxytryptamine And Dopamine Receptor Antagonists Image Figure 8. Global Second-Generation Antipsychotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Second-Generation Antipsychotics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adjuvant Treatment For Depression Image Figure 11. Bipolar Disorder Image Figure 12. Schizophrenia Image Figure 13. Other Mental Illnesses Image Figure 14. Global Second-Generation Antipsychotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Second-Generation Antipsychotics Revenue (2021-2032) & (US$ Million) Figure 16. Global Second-Generation Antipsychotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Second-Generation Antipsychotics Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Second-Generation Antipsychotics Revenue Market Share by Region (2021-2032) Figure 19. Global Second-Generation Antipsychotics Sales (2021-2032) & (units) Figure 20. Global Second-Generation Antipsychotics Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 21. Global Second-Generation Antipsychotics Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Second-Generation Antipsychotics Sales YoY (2021-2032) & (units) Figure 23. Europe Second-Generation Antipsychotics Sales YoY (2021-2032) & (units) Figure 24. China Second-Generation Antipsychotics Sales YoY (2021-2032) & (units) Figure 25. Asia (Excluding China) Second-Generation Antipsychotics Sales YoY (2021-2032) & (units) Figure 26. South America, Middle East and Africa Second-Generation Antipsychotics Sales YoY (2021-2032) & (units) Figure 27. Global Second-Generation Antipsychotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Second-Generation Antipsychotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Second-Generation Antipsychotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Second-Generation Antipsychotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Second-Generation Antipsychotics Revenue Market Share by Type (2021-2032) Figure 33. Global Second-Generation Antipsychotics Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 34. Global Second-Generation Antipsychotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Second-Generation Antipsychotics Sales Market Share by Type (2021-2032) Figure 36. Global Second-Generation Antipsychotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Second-Generation Antipsychotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Second-Generation Antipsychotics Revenue Market Share by Application (2021-2032) Figure 39. Global Second-Generation Antipsychotics Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 40. Global Second-Generation Antipsychotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Second-Generation Antipsychotics Sales Market Share by Application (2021-2032) Figure 42. North America Second-Generation Antipsychotics Revenue Share by Type (2021-2032) Figure 43. North America Second-Generation Antipsychotics Sales Share by Type (2021-2032) Figure 44. North America Second-Generation Antipsychotics Revenue Share by Application (2021-2032) Figure 45. North America Second-Generation Antipsychotics Sales Share by Application (2021-2032) Figure 46. North America Second-Generation Antipsychotics Revenue Share by Country (2021-2032) Figure 47. North America Second-Generation Antipsychotics Sales Share by Country (2021-2032) Figure 48. Europe Second-Generation Antipsychotics Revenue Share by Type (2021-2032) Figure 49. Europe Second-Generation Antipsychotics Sales Share by Type (2021-2032) Figure 50. Europe Second-Generation Antipsychotics Revenue Share by Application (2021-2032) Figure 51. Europe Second-Generation Antipsychotics Sales Share by Application (2021-2032) Figure 52. Europe Second-Generation Antipsychotics Revenue Share by Country (2021-2032) Figure 53. Europe Second-Generation Antipsychotics Sales Share by Country (2021-2032) Figure 54. China Second-Generation Antipsychotics Revenue Share by Type (2021-2032) Figure 55. China Second-Generation Antipsychotics Sales Share by Type (2021-2032) Figure 56. China Second-Generation Antipsychotics Revenue Share by Application (2021-2032) Figure 57. China Second-Generation Antipsychotics Sales Share by Application (2021-2032) Figure 58. Asia Second-Generation Antipsychotics Revenue Share by Type (2021-2032) Figure 59. Asia Second-Generation Antipsychotics Sales Share by Type (2021-2032) Figure 60. Asia Second-Generation Antipsychotics Revenue Share by Application (2021-2032) Figure 61. Asia Second-Generation Antipsychotics Sales Share by Application (2021-2032) Figure 62. Asia Second-Generation Antipsychotics Revenue Share by Country (2021-2032) Figure 63. Asia Second-Generation Antipsychotics Sales Share by Country (2021-2032) Figure 64. SAMEA Second-Generation Antipsychotics Revenue Share by Type (2021-2032) Figure 65. SAMEA Second-Generation Antipsychotics Sales Share by Type (2021-2032) Figure 66. SAMEA Second-Generation Antipsychotics Revenue Share by Application (2021-2032) Figure 67. SAMEA Second-Generation Antipsychotics Sales Share by Application (2021-2032) Figure 68. SAMEA Second-Generation Antipsychotics Revenue Share by Country (2021-2032) Figure 69. SAMEA Second-Generation Antipsychotics Sales Share by Country (2021-2032) Figure 70. Second-Generation Antipsychotics Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Second-Gene

Scope & coverage.

Types
  • Selective Dopamine Receptor Antagonists
  • Multi Receptor Acting Drugs
  • Dopamine Receptor Partial Agonists
  • 5-Hydroxytryptamine And Dopamine Receptor Antagonists
Applications
  • Adjuvant Treatment For Depression
  • Bipolar Disorder
  • Schizophrenia
  • Other Mental Illnesses
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • CSPC Pharmaceutical Group
  • Qilu Pharmaceutical
  • Novartis
  • Merck
  • Luye Pharma Group
  • Roche
  • Livzon Pharmaceutical Group
  • Eli Lilly
  • Chengdu Kanghong Pharmaceutical
  • Pfizer
  • Hansoh Pharma
  • Hisun Pharmaceutical
  • Nhwa Pharmaceutical
  • AbbVie
  • Sumitomo Dainippon Pharma
  • Otsuka Pharmaceutical
  • Johnson And Johnson
  • Ipsen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Second-Generation Antipsychotics Market by Type
  3. 1.2.1 Global Second-Generation Antipsychotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Selective Dopamine Receptor Antagonists
  5. 1.2.3 Multi Receptor Acting Drugs
  6. 1.2.4 Dopamine Receptor Partial Agonists
  7. 1.2.5 5-Hydroxytryptamine And Dopamine Receptor Antagonists
  8. 1.3 Second-Generation Antipsychotics Market by Application
  9. 1.3.1 Global Second-Generation Antipsychotics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adjuvant Treatment For Depression
  11. 1.3.3 Bipolar Disorder
  12. 1.3.4 Schizophrenia
  13. 1.3.5 Other Mental Illnesses
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Second-Generation Antipsychotics Market Dynamics
  1. 2.1 Second-Generation Antipsychotics Industry Trends
  2. 2.2 Second-Generation Antipsychotics Industry Drivers
  3. 2.3 Second-Generation Antipsychotics Industry Opportunities and Challenges
  4. 2.4 Second-Generation Antipsychotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Second-Generation Antipsychotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Second-Generation Antipsychotics Revenue by Region
  3. 3.2.1 Global Second-Generation Antipsychotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Second-Generation Antipsychotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Second-Generation Antipsychotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Second-Generation Antipsychotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Second-Generation Antipsychotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Second-Generation Antipsychotics Sales by Region
  9. 3.4.1 Global Second-Generation Antipsychotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Second-Generation Antipsychotics Sales by Region (2021-2026)
  11. 3.4.3 Global Second-Generation Antipsychotics Sales by Region (2027-2032)
  12. 3.4.4 Global Second-Generation Antipsychotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Second-Generation Antipsychotics Revenue by Manufacturers
  2. 4.1.1 Global Second-Generation Antipsychotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Second-Generation Antipsychotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Second-Generation Antipsychotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Second-Generation Antipsychotics Sales by Manufacturers
  6. 4.2.1 Global Second-Generation Antipsychotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Second-Generation Antipsychotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Second-Generation Antipsychotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Second-Generation Antipsychotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Second-Generation Antipsychotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Second-Generation Antipsychotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Second-Generation Antipsychotics Manufacturers, Product Type & Application
  13. 4.7 Global Second-Generation Antipsychotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Second-Generation Antipsychotics Market CR5 and HHI
  16. 4.8.2 2025 Second-Generation Antipsychotics Tier 1, Tier 2, and Tier 3
5 Second-Generation Antipsychotics Market by Type
  1. 5.1 Global Second-Generation Antipsychotics Revenue by Type
  2. 5.1.1 Global Second-Generation Antipsychotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Second-Generation Antipsychotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Second-Generation Antipsychotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Second-Generation Antipsychotics Sales by Type
  6. 5.2.1 Global Second-Generation Antipsychotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Second-Generation Antipsychotics Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Second-Generation Antipsychotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Second-Generation Antipsychotics Price by Type
6 Second-Generation Antipsychotics Market by Application
  1. 6.1 Global Second-Generation Antipsychotics Revenue by Application
  2. 6.1.1 Global Second-Generation Antipsychotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Second-Generation Antipsychotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Second-Generation Antipsychotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Second-Generation Antipsychotics Sales by Application
  6. 6.2.1 Global Second-Generation Antipsychotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Second-Generation Antipsychotics Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Second-Generation Antipsychotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Second-Generation Antipsychotics Price by Application
7 Company Profiles
  1. 7.1 Chia Tai Tianqing Pharmaceutical
  2. 7.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 7.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 7.1.3 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Portfolio
  6. 7.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 7.2 Yangtze River Pharmaceutical Group
  8. 7.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 7.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 7.2.3 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio
  12. 7.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 7.3 CSPC Pharmaceutical Group
  14. 7.3.1 CSPC Pharmaceutical Group Company Information
  15. 7.3.2 CSPC Pharmaceutical Group Business Overview
  16. 7.3.3 CSPC Pharmaceutical Group Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio
  18. 7.3.5 CSPC Pharmaceutical Group Recent Developments
  19. 7.4 Qilu Pharmaceutical
  20. 7.4.1 Qilu Pharmaceutical Company Information
  21. 7.4.2 Qilu Pharmaceutical Business Overview
  22. 7.4.3 Qilu Pharmaceutical Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Qilu Pharmaceutical Second-Generation Antipsychotics Product Portfolio
  24. 7.4.5 Qilu Pharmaceutical Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Second-Generation Antipsychotics Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck Second-Generation Antipsychotics Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Luye Pharma Group
  38. 7.7.1 Luye Pharma Group Company Information
  39. 7.7.2 Luye Pharma Group Business Overview
  40. 7.7.3 Luye Pharma Group Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Luye Pharma Group Second-Generation Antipsychotics Product Portfolio
  42. 7.7.5 Luye Pharma Group Recent Developments
  43. 7.8 Roche
  44. 7.8.1 Roche Company Information
  45. 7.8.2 Roche Business Overview
  46. 7.8.3 Roche Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche Second-Generation Antipsychotics Product Portfolio
  48. 7.8.5 Roche Recent Developments
  49. 7.9 Livzon Pharmaceutical Group
  50. 7.9.1 Livzon Pharmaceutical Group Company Information
  51. 7.9.2 Livzon Pharmaceutical Group Business Overview
  52. 7.9.3 Livzon Pharmaceutical Group Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio
  54. 7.9.5 Livzon Pharmaceutical Group Recent Developments
  55. 7.10 Eli Lilly
  56. 7.10.1 Eli Lilly Company Information
  57. 7.10.2 Eli Lilly Business Overview
  58. 7.10.3 Eli Lilly Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Eli Lilly Second-Generation Antipsychotics Product Portfolio
  60. 7.10.5 Eli Lilly Recent Developments
  61. 7.11 Chengdu Kanghong Pharmaceutical
  62. 7.11.1 Chengdu Kanghong Pharmaceutical Company Information
  63. 7.11.2 Chengdu Kanghong Pharmaceutical Business Overview
  64. 7.11.3 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Portfolio
  66. 7.11.5 Chengdu Kanghong Pharmaceutical Recent Developments
  67. 7.12 Pfizer
  68. 7.12.1 Pfizer Company Information
  69. 7.12.2 Pfizer Business Overview
  70. 7.12.3 Pfizer Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pfizer Second-Generation Antipsychotics Product Portfolio
  72. 7.12.5 Pfizer Recent Developments
  73. 7.13 Hansoh Pharma
  74. 7.13.1 Hansoh Pharma Company Information
  75. 7.13.2 Hansoh Pharma Business Overview
  76. 7.13.3 Hansoh Pharma Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hansoh Pharma Second-Generation Antipsychotics Product Portfolio
  78. 7.13.5 Hansoh Pharma Recent Developments
  79. 7.14 Hisun Pharmaceutical
  80. 7.14.1 Hisun Pharmaceutical Company Information
  81. 7.14.2 Hisun Pharmaceutical Business Overview
  82. 7.14.3 Hisun Pharmaceutical Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hisun Pharmaceutical Second-Generation Antipsychotics Product Portfolio
  84. 7.14.5 Hisun Pharmaceutical Recent Developments
  85. 7.15 Nhwa Pharmaceutical
  86. 7.15.1 Nhwa Pharmaceutical Company Information
  87. 7.15.2 Nhwa Pharmaceutical Business Overview
  88. 7.15.3 Nhwa Pharmaceutical Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Nhwa Pharmaceutical Second-Generation Antipsychotics Product Portfolio
  90. 7.15.5 Nhwa Pharmaceutical Recent Developments
  91. 7.16 AbbVie
  92. 7.16.1 AbbVie Company Information
  93. 7.16.2 AbbVie Business Overview
  94. 7.16.3 AbbVie Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AbbVie Second-Generation Antipsychotics Product Portfolio
  96. 7.16.5 AbbVie Recent Developments
  97. 7.17 Sumitomo Dainippon Pharma
  98. 7.17.1 Sumitomo Dainippon Pharma Company Information
  99. 7.17.2 Sumitomo Dainippon Pharma Business Overview
  100. 7.17.3 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Portfolio
  102. 7.17.5 Sumitomo Dainippon Pharma Recent Developments
  103. 7.18 Otsuka Pharmaceutical
  104. 7.18.1 Otsuka Pharmaceutical Company Information
  105. 7.18.2 Otsuka Pharmaceutical Business Overview
  106. 7.18.3 Otsuka Pharmaceutical Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Otsuka Pharmaceutical Second-Generation Antipsychotics Product Portfolio
  108. 7.18.5 Otsuka Pharmaceutical Recent Developments
  109. 7.19 Johnson And Johnson
  110. 7.19.1 Johnson And Johnson Company Information
  111. 7.19.2 Johnson And Johnson Business Overview
  112. 7.19.3 Johnson And Johnson Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Johnson And Johnson Second-Generation Antipsychotics Product Portfolio
  114. 7.19.5 Johnson And Johnson Recent Developments
  115. 7.20 Ipsen
  116. 7.20.1 Ipsen Company Information
  117. 7.20.2 Ipsen Business Overview
  118. 7.20.3 Ipsen Second-Generation Antipsychotics Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Ipsen Second-Generation Antipsychotics Product Portfolio
  120. 7.20.5 Ipsen Recent Developments
8 North America
  1. 8.1 North America Second-Generation Antipsychotics Market Size by Type
  2. 8.1.1 North America Second-Generation Antipsychotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Second-Generation Antipsychotics Sales by Type (2021-2032)
  4. 8.1.3 North America Second-Generation Antipsychotics Price by Type (2021-2032)
  5. 8.2 North America Second-Generation Antipsychotics Market Size by Application
  6. 8.2.1 North America Second-Generation Antipsychotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Second-Generation Antipsychotics Sales by Application (2021-2032)
  8. 8.2.3 North America Second-Generation Antipsychotics Price by Application (2021-2032)
  9. 8.3 North America Second-Generation Antipsychotics Market Size by Country
  10. 8.3.1 North America Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Second-Generation Antipsychotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Second-Generation Antipsychotics Market Size by Type
  2. 9.1.1 Europe Second-Generation Antipsychotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Second-Generation Antipsychotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Second-Generation Antipsychotics Price by Type (2021-2032)
  5. 9.2 Europe Second-Generation Antipsychotics Market Size by Application
  6. 9.2.1 Europe Second-Generation Antipsychotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Second-Generation Antipsychotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Second-Generation Antipsychotics Price by Application (2021-2032)
  9. 9.3 Europe Second-Generation Antipsychotics Market Size by Country
  10. 9.3.1 Europe Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Second-Generation Antipsychotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Second-Generation Antipsychotics Market Size by Type
  2. 10.1.1 China Second-Generation Antipsychotics Revenue by Type (2021-2032)
  3. 10.1.2 China Second-Generation Antipsychotics Sales by Type (2021-2032)
  4. 10.1.3 China Second-Generation Antipsychotics Price by Type (2021-2032)
  5. 10.2 China Second-Generation Antipsychotics Market Size by Application
  6. 10.2.1 China Second-Generation Antipsychotics Revenue by Application (2021-2032)
  7. 10.2.2 China Second-Generation Antipsychotics Sales by Application (2021-2032)
  8. 10.2.3 China Second-Generation Antipsychotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Second-Generation Antipsychotics Market Size by Type
  2. 11.1.1 Asia Second-Generation Antipsychotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Second-Generation Antipsychotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Second-Generation Antipsychotics Price by Type (2021-2032)
  5. 11.2 Asia Second-Generation Antipsychotics Market Size by Application
  6. 11.2.1 Asia Second-Generation Antipsychotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Second-Generation Antipsychotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Second-Generation Antipsychotics Price by Application (2021-2032)
  9. 11.3 Asia Second-Generation Antipsychotics Market Size by Country
  10. 11.3.1 Asia Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Second-Generation Antipsychotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Second-Generation Antipsychotics Market Size by Type
  2. 12.1.1 SAMEA Second-Generation Antipsychotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Second-Generation Antipsychotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Second-Generation Antipsychotics Price by Type (2021-2032)
  5. 12.2 SAMEA Second-Generation Antipsychotics Market Size by Application
  6. 12.2.1 SAMEA Second-Generation Antipsychotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Second-Generation Antipsychotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Second-Generation Antipsychotics Price by Application (2021-2032)
  9. 12.3 SAMEA Second-Generation Antipsychotics Market Size by Country
  10. 12.3.1 SAMEA Second-Generation Antipsychotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Second-Generation Antipsychotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Second-Generation Antipsychotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Second-Generation Antipsychotics Value Chain Analysis
  2. 13.1.1 Second-Generation Antipsychotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Second-Generation Antipsychotics Production Mode & Process
  6. 13.2 Second-Generation Antipsychotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Second-Generation Antipsychotics Distributors
  9. 13.2.3 Second-Generation Antipsychotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst